Filing Details

Accession Number:
0001181431-10-041124
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-08-10 13:00:00
Reporting Period:
2010-08-06
Filing Date:
2010-08-10
Accepted Time:
2010-08-10 13:50:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1356857 Trius Therapeutics Inc TSRX Pharmaceutical Preparations (2834) 201320630
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1381980 S Nina Kjellson C/o Trius Therapeutics, Inc.
6310 Nancy Ridge Drive, Suite 101
San Diego CA 92121
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-08-06 1,576,814 $0.00 1,576,814 No 4 C Indirect See Footnote
Common Stock Acquisiton 2010-08-06 744,496 $4.38 2,321,310 No 4 C Indirect See Footnote
Common Stock Acquisiton 2010-08-06 1,227,333 $5.00 3,548,643 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A-2 Convertible Preferred Stock Disposition 2010-08-06 9,090,910 $0.00 9,090,910 $0.00
Common Stock Series B Convertible Preferred Stock Disposition 2010-08-06 4,469,697 $0.00 4,469,697 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Upon the closing of the Issuer's initial public offering, each 8.6 shares of the Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into one share of Common Stock, and had no expiration date.
  2. The shares are held by InterWest Partners IX, L.P. The Reporting Person shares voting and investment authority over the shares held by InterWest Partners IX, L.P. The Reporting Person may be deemed to beneficially own the shares and disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein.
  3. The Common Stock was acquired upon conversion of a Secured Convertible Promissory Note exempt from the definition of a derivative security and whose conversion ratio did not become fixed until automatic conversion at the time of the closing of the Issuer's initial public offering.
  4. The shares were purchased in the Issuer's initial public offering and are held by InterWest Partners IX, L.P. The Reporting Person shares voting and investment authority over the shares held by InterWest Partners IX, L.P. The Reporting Person may be deemed to beneficially own the shares and disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein.